Compare CLDX & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | PLUS |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 1995 | 1996 |
| Metric | CLDX | PLUS |
|---|---|---|
| Price | $33.93 | $79.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.60 | N/A |
| AVG Volume (30 Days) | ★ 913.4K | 272.0K |
| Earning Date | 05-04-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | N/A | ★ 24.20 |
| EPS | N/A | ★ 5.03 |
| Revenue | $12,743,000.00 | ★ $2,442,549,000.00 |
| Revenue This Year | $111.39 | $19.83 |
| Revenue Next Year | $235.85 | $4.36 |
| P/E Ratio | ★ N/A | $16.12 |
| Revenue Growth | ★ 87.78 | 18.07 |
| 52 Week Low | $19.52 | $62.11 |
| 52 Week High | $35.83 | $93.98 |
| Indicator | CLDX | PLUS |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 41.56 |
| Support Level | $28.51 | $77.97 |
| Resistance Level | $35.10 | $90.93 |
| Average True Range (ATR) | 1.23 | 3.39 |
| MACD | 0.43 | -0.29 |
| Stochastic Oscillator | 78.89 | 22.00 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.